Type 2 diabetes and multidrug-resistant tuberculosis
- 1 January 2008
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 40 (11-12), 888-893
- https://doi.org/10.1080/00365540802342372
Abstract
The association between tuberculosis (TB) and diabetes is re-emerging with the epidemic of type 2 diabetes (T2DM). We analyzed retrospective data from 2878 TB patients across the Texas/Mexico border. Overall, 161/2878 (5.6%) patients had MDR TB (resistance to rifampin and isoniazid): Texas 49/1442 (3.4%) and Mexico 112/1436 (7.8%). In Texas, MDR TB was significantly associated with T2DM (OR 2.1, 95% CI 1.1–4.2) when adjusted for age, gender, drug and alcohol abuse, HIV infection and history of previous episode of TB; and in Mexico (OR 1.80, 95% CI 1.1–2.9) when adjusted for age and gender. Patients with T2DM in both countries were more likely to be compliant with DOTS therapy (Texas: OR 2.4, 95% CI 1.1–5.4) than patients without T2DM. In Texas, all but 3 of the T2DM patients with MDR TB were resistant at their first culture at the time of diagnosis. It is possible that impaired immunity in T2DM increases susceptibility to infection with resistant strains.Keywords
This publication has 25 references indexed in Scilit:
- Tuberculosis in Poorly Controlled Type 2 Diabetes: Altered Cytokine Expression in Peripheral White Blood CellsClinical Infectious Diseases, 2008
- Tuberculosis Susceptibility of Diabetic MiceAmerican Journal of Respiratory Cell and Molecular Biology, 2007
- Malnutrition and Infection: Complex Mechanisms and Global ImpactsPLoS Medicine, 2007
- Worldwide Emergence of Extensively Drug-resistant TuberculosisEmerging Infectious Diseases, 2007
- Exposure to Rifampicin Is Strongly Reduced in Patients with Tuberculosis and Type 2 DiabetesClinical Infectious Diseases, 2006
- Type 2 diabetes and tuberculosis in a dynamic bi-national border populationEpidemiology and Infection, 2006
- Impact of Bacterial Genetics on the Transmission of Isoniazid-Resistant Mycobacterium tuberculosisPLoS Pathogens, 2006
- A Multidrug‐Resistant,acr1‐Deficient Clinical Isolate ofMycobacterium tuberculosisIs Unimpaired for Replication in MacrophagesThe Journal of Infectious Diseases, 2006
- Tuberculosis and Diabetes in Southern MexicoDiabetes Care, 2004
- Global and societal implications of the diabetes epidemicNature, 2001